98 related articles for article (PubMed ID: 29954586)
21. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208
[TBL] [Abstract][Full Text] [Related]
22. Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra.
Suárez I; Bodega G; Ramos JA; Fernández-Ruiz JJ; Fernández B
Dev Neurosci; 2000; 22(4):253-63. PubMed ID: 10965147
[TBL] [Abstract][Full Text] [Related]
23. Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease.
Viereckel T; Dumas S; Smith-Anttila CJ; Vlcek B; Bimpisidis Z; Lagerström MC; Konradsson-Geuken Å; Wallén-Mackenzie Å
Sci Rep; 2016 Oct; 6():35203. PubMed ID: 27762319
[TBL] [Abstract][Full Text] [Related]
24. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
Xu X; Song N; Wang R; Jiang H; Xie J
Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
[TBL] [Abstract][Full Text] [Related]
25. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
[TBL] [Abstract][Full Text] [Related]
26. Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment.
McArthur S; Pienaar IS; Siddiqi SM; Gillies GE
Brain Struct Funct; 2016 Jun; 221(5):2459-75. PubMed ID: 25944572
[TBL] [Abstract][Full Text] [Related]
27. Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats.
Souza MF; Freire MAM; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Leal PC; Engelberth RCGJ; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Brain Res Bull; 2018 Sep; 142():297-303. PubMed ID: 30118749
[TBL] [Abstract][Full Text] [Related]
28. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
29. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
Stayte S; Rentsch P; Li KM; Vissel B
PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
[TBL] [Abstract][Full Text] [Related]
30. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease.
Sugama S; Kakinuma Y
Neurosci Res; 2016 Oct; 111():48-55. PubMed ID: 27142317
[TBL] [Abstract][Full Text] [Related]
31. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
Winter C; von Rumohr A; Mundt A; Petrus D; Klein J; Lee T; Morgenstern R; Kupsch A; Juckel G
Behav Brain Res; 2007 Dec; 184(2):133-41. PubMed ID: 17698212
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats.
Brambilla Bagatini P; Xavier LL; Neves L; Saur L; Barbosa S; Baptista PP; Augustin OA; Nunes de Senna P; Mestriner RG; Souto AA; Achaval M
Brain Res; 2014 Dec; 1592():101-12. PubMed ID: 25446006
[TBL] [Abstract][Full Text] [Related]
33. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
[TBL] [Abstract][Full Text] [Related]
34. The hTH-GFP reporter rat model for the study of Parkinson's disease.
Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
[TBL] [Abstract][Full Text] [Related]
35. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
[TBL] [Abstract][Full Text] [Related]
36. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
[TBL] [Abstract][Full Text] [Related]
37. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
38. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
Gale SD; Perkel DJ
J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
[TBL] [Abstract][Full Text] [Related]
39. Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis.
Gomide V; Chadi G
Int J Neurosci; 2005 Apr; 115(4):537-55. PubMed ID: 15809219
[TBL] [Abstract][Full Text] [Related]
40. Nuclear organization of the substantia nigra, ventral tegmental area and retrorubral field of the common marmoset (Callithrix jacchus): A cytoarchitectonic and TH-immunohistochemistry study.
Cavalcanti JRLP; Pontes ALB; Fiuza FP; Silva KDA; Guzen FP; Lucena EES; Nascimento-Júnior ES; Cavalcante JC; Costa MSMO; Engelberth RCGJ; Cavalcante JS
J Chem Neuroanat; 2016 Nov; 77():100-109. PubMed ID: 27292410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
